We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry Shares How Far It’s Come on Transparency After Concerns Raised
Industry Shares How Far It’s Come on Transparency After Concerns Raised
December 14, 2015
The pharmaceutical industry is becoming more active in sharing clinical trial data in a way that may have seemed inconceivable 20 years ago, drugmakers said, even as it has taken heat for being opaque on disclosures.